FDC Limited (BOM:531599)
330.15
-1.00 (-0.30%)
At close: Mar 25, 2026
FDC Limited Market Cap
FDC Limited has a market cap or net worth of 53.75 billion as of March 27, 2026. Its market cap has decreased by -17.60% in one year.
Market Cap
53.75B
Enterprise Value
49.71B
Revenue
20.78B
Ranking
n/a
PE Ratio
24.82
Stock Price
330.15
Market Cap Chart
Since May 30, 2002, FDC Limited's market cap has increased from 2.73B to 53.75B, an increase of 1,870.71%. That is a compound annual growth rate of 13.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 53.75B | -22.01% |
| Dec 31, 2025 | 68.92B | -15.14% |
| Dec 31, 2024 | 81.22B | 25.96% |
| Dec 29, 2023 | 64.48B | 43.15% |
| Dec 30, 2022 | 45.04B | -12.27% |
| Dec 31, 2021 | 51.34B | -8.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 136.99B |
| Rubicon Research | 127.45B |
| Caplin Point Laboratories | 121.29B |
| CORONA Remedies | 96.79B |
| Viyash Scientific | 84.52B |
| Procter & Gamble Health | 81.99B |
| Sanofi India | 76.42B |
| Gufic Biosciences | 29.26B |